United States: Troutman Sanders Tobacco Team Moderates A Session At The Food And Drug Law Institute 2017 Annual Conference
Last Updated: May 10 2017

On Thursday, May 4, 2017, Bryan M. Haynes, Partner, Troutman Sanders LLP, will moderate a session on the FDA Center for Tobacco Products' Evaluation of Premarket and Modified Risk Tobacco Product Applications at the 2017 Food and Drug Law Institute Annual Conference, which will be held in Washington, DC. This session will include a discussion of the FDA's standards for reviewing premarket tobacco applications, as well as modified risk tobacco applications.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

 
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Press Releases from this Firm
Recent Content from this Firm
By Adrienne Thompson, Thomas S. DeVita
By Adrienne Thompson, Thomas S. DeVita
By Russell Kooistra, Jasmine C. Hites
By Andrea Wortzel, Angela Levin, Justin Wong
By Troutman Sanders
By Troutman Sanders
By William Derasmo, Clifford Sikora
By Brooke Conkle, Michael Lacy
By Brooke Conkle, Alan Wingfield
By Andrea Wortzel, Angela Levin, Laura Boorman
Tools
Print
Font Size:
Translation
Channels